Antibody binding activity specific to monocyte scavenger receptor CD36 is frequently detectable in the plasma of patients with antiphospholipid syndrome
Restricted accessLetterFirst published online October, 2023
Antibody binding activity specific to monocyte scavenger receptor CD36 is frequently detectable in the plasma of patients with antiphospholipid syndrome
Ruiz-IrastorzaGCrowtherMBranchW, et al.Antiphospholipid syndrome. Lancet2010; 376: 1498–1509.
2.
BohgakiMAtsumiTYamashitaY, et al.The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies. Int Immunol2004; 16: 1633–1641.
3.
Vega-OstertagMCasperKSwerlickR, et al.Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum2005; 52: 1545–1554.
4.
OkuKAmengualOZigonP, et al.Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody. Rheumatology2013; 52: 1775–1784.
5.
KatoMAtsumiTOkuK, et al.The involvement of CD36 in monocyte activation by antiphospholipid antibodies. Lupus2013; 22: 761–771.
6.
ReissABWanDWAnwarK, et al.Enhanced CD36 scavenger receptor expression in THP-1 human monocytes in the presence of lupus plasma: linking autoimmunity and atherosclerosis. Exp Biol Med2009; 234: 354–360.
7.
PelegriYCerratoGMartinuzzoME, et al.Link between anti-CD36 antibodies and thrombosis in the antiphospholipid syndrome. Clin Exp Rheumatol2003; 21: 221–224.
8.
RockGChauhanKJamiesonGA, et al.Anti-CD36 antibodies in patients with lupus anticoagulant and thrombotic complications. Br J Haematol1994; 88: 878–880.
9.
KaneshigeRNojimaJMotokiY, et al.aCL/β2GPI and aPS/PT show synergic thrombogenic effects in suppressing anticoagulant activity of APC and stimulating tissue factor expression and TNF-α secretion by mononuclear cells. Thromb Res2019; 181: 52–58.
10.
SilversteinRL. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med2009; 76(Suppl 2): S27–S30.
